Spring 2025
By Bethany Herrema
Mohammad Rashidian, PhD, received The International Myeloma Society and Paula and Rodger Riney Foundation Translational Research Award. He will use his $250,000 grant to empower investigations to address the challenge of disease relapse in patients treated with a specific type of CAR T-cell therapy. Such studies hold great promise in extending the efficacy of this treatment option.